Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

11.10.2021

1 Acta Neuropathol
3 Alzheimer Dis Assoc Disord
1 Ann Neurol
4 BMC Neurol
3 Brain
1 Brain Res
2 Curr Alzheimer Res
10 J Alzheimers Dis
1 J Biol Chem
2 J Neurol
1 Memory
3 Nat Med
1 Nat Rev Neurol
2 Neurology
1 Neurosci Lett
1 PLoS One
1 Rev Neurol



    Acta Neuropathol

  1. MCALEESE KE, Miah M, Graham S, Hadfield GM, et al
    Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    Acta Neuropathol. 2021 Oct 4. pii: 10.1007/s00401-021-02376.
    >> Share


    Alzheimer Dis Assoc Disord

  2. VLACHOS GS, Kosmidis MH, Yannakoulia M, Dardiotis E, et al
    Dementia Incidence in the Elderly Population of Greece: Results From the HELIAD Study.
    Alzheimer Dis Assoc Disord. 2021;35:48-54.
    >> Share

  3. NGUYEN XV, Candemir S, Erdal BS, White RD, et al
    Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data.
    Alzheimer Dis Assoc Disord. 2021;35:1-7.
    >> Share

  4. GOMBOSEV A, Salazar CR, Hoang D, Cox CG, et al
    Direct Mail Recruitment to a Potential Participant Registry.
    Alzheimer Dis Assoc Disord. 2021;35:80-83.
    >> Share


    Ann Neurol

  5. DAS SR, Lyu X, Duong MT, Xie L, et al
    Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer's disease.
    Ann Neurol. 2021 Oct 7. doi: 10.1002/ana.26233.
    >> Share


    BMC Neurol

  6. MOLINDER A, Ziegelitz D, Maier SE, Eckerstrom C, et al
    Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    BMC Neurol. 2021;21:289.
    >> Share

  7. AXENHUS M, Bogdanovic N
    Confusion, cognitive impairment, and spinal cord compression caused by plasmacytoma: a case report.
    BMC Neurol. 2021;21:303.
    >> Share

  8. WANG XL, Li L
    Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's Disease.
    BMC Neurol. 2021;21:381.
    >> Share

  9. ZHAO LJ, Wang ZT, Ma YH, Zhang W, et al
    Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function.
    BMC Neurol. 2021;21:387.
    >> Share


    Brain

  10. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    >> Share

  11. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    >> Share

  12. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    >> Share


    Brain Res

  13. ZHENG SN, Pan L, Liao AM, Hou YC, et al
    Wheat Embryo Globulin Nutrients Ameliorate D-galactose and Aluminum Chloride-Induced Cognitive Impairment in Rats.
    Brain Res. 2021 Oct 1:147672. doi: 10.1016/j.brainres.2021.147672.
    >> Share


    Curr Alzheimer Res

  14. WANG Y, Lou F, Li Y, Liu F, et al
    Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid-positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Curr Alzheimer Res. 2021 Oct 1. pii: CAR-EPUB-118260.
    >> Share

  15. YAN Y, Zhao A, Qiu Y, Ding Y, et al
    Functional Connectivity Alterations Based on the Weighted Phase Lag Index: An Exploratory Electroencephalography Study on Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Oct 1. pii: CAR-EPUB-118259.
    >> Share


    J Alzheimers Dis

  16. SHAFIEE N, Dadar M, Ducharme S, Collins DL, et al
    Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 1. pii: JAD210664. doi: 10.3233/JAD-210664.
    >> Share

  17. LARGENT EA, Bhardwaj T, Abera M, Stites SD, et al
    Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
    J Alzheimers Dis. 2021 Sep 30. pii: JAD210675. doi: 10.3233/JAD-210675.
    >> Share

  18. ROBINSON AC, Davidson YS, Roncaroli F, Minshull J, et al
    Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer's Disease Pathology at Death.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215102. doi: 10.3233/JAD-215102.
    >> Share

  19. STANITSA E, Economou A, Beratis I, Kontaxopoulou D, et al
    Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210622. doi: 10.3233/JAD-210622.
    >> Share

  20. SONG J, Yang X, Zhang M, Wang C, et al
    Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210595. doi: 10.3233/JAD-210595.
    >> Share

  21. PANDEY JP, Namboodiri AM, Nietert PJ, Barnes LL, et al
    Inhibitory Fcgamma Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215174. doi: 10.3233/JAD-215174.
    >> Share

  22. HAO J, Qiao Y, Li T, Yang J, et al
    Investigating Changes in the Serum Inflammatory Factors in Alzheimer's Disease and Their Correlation with Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210552. doi: 10.3233/JAD-210552.
    >> Share

  23. FUKUDA H, Ono R, Maeda M, Murata F, et al
    Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD201508. doi: 10.3233/JAD-201508.
    >> Share

  24. SONG XJ, Zhou HY, Sun YY, Huang HC, et al
    Phosphorylation and Glycosylation of Amyloid-beta Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210337. doi: 10.3233/JAD-210337.
    >> Share

  25. MATSUZONO K, Suzuki M, Miura K, Ozawa T, et al
    Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210490. doi: 10.3233/JAD-210490.
    >> Share


    J Biol Chem

  26. LIU H, Kim C, Haldiman T, Sigurdson CJ, et al
    Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease.
    J Biol Chem. 2021 Sep 29:101267. doi: 10.1016/j.jbc.2021.101267.
    >> Share


    J Neurol

  27. PLEEN J, Townley R
    Alzheimer's disease clinical trial update 2019-2021.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10790.
    >> Share

  28. ARMON C, Wolfson S, Margalit R, Avraham L, et al
    Estimating the X chromosome-mediated risk for developing Alzheimer's disease.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10826.
    >> Share


    Memory

  29. EL HAJ M, Robin F
    Repeated recall on source misattribution in Alzheimer's disease.
    Memory. 2021 Oct 4:1-8. doi: 10.1080/09658211.2021.1985521.
    >> Share


    Nat Med

  30. PASCOAL TA, Benedet AL, Ashton NJ, Kang MS, et al
    Microglial activation and tau propagate jointly across Braak stages.
    Nat Med. 2021;27:1592-1599.
    >> Share

  31. CUMMINGS J
    Why aducanumab is important.
    Nat Med. 2021;27:1498.
    >> Share

  32. PERLMUTTER JS
    Aducanumab: look before leaping.
    Nat Med. 2021;27:1499.
    >> Share


    Nat Rev Neurol

  33. LEMPRIERE S
    Genome-wide association study identifies new risk loci for Alzheimer disease.
    Nat Rev Neurol. 2021 Oct 1. pii: 10.1038/s41582-021-00575.
    >> Share


    Neurology

  34. HERSHEY LA, Tarawneh R
    Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?
    Neurology. 2021;97:517-518.
    >> Share

  35. JEONG SH, Kim HR, Kim J, Kim H, et al
    Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.
    Neurology. 2021;97:e1110-e1122.
    >> Share


    Neurosci Lett

  36. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    >> Share


    PLoS One

  37. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    >> Share


    Rev Neurol

  38. DAL-RE R
    [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].
    Rev Neurol. 2021;73:296-297.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016